Skip to main content
رجوع
OMER logo

Omeros Corporation

جودة البيانات: 100%
OMER
NASDAQ Healthcare Biotechnology
KWD 10.66
▼ KWD 0.34 (-3.09%)
القيمة السوقية: 755.80M
نطاق اليوم
KWD 10.59 KWD 11.44
نطاق 52 أسبوعًا
KWD 2.95 KWD 17.65
حجم التداول
1,185,013
متوسط 50 يوم / 200 يوم
KWD 11.75 / KWD 7.57
الإغلاق السابق
KWD 11.00

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (626 نظير)

المقياس السهم وسيط القطاع
P/E -4.8 0.4
P/B 2.9
ROE % 3.8
Net Margin % 3.9
Rev Growth 5Y % 10.0
D/E 0.2

السعر المستهدف للمحللين

Hold
KWD 40.000 +275.2%
ربحية السهم المستقبلية
-KWD 0.534
الإيرادات المقدّرة
120 M

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2029 KWD 4.920
-KWD 0.211 – KWD 18.205
780 M 1
FY2028 KWD 2.983
-KWD 0.128 – KWD 11.039
520 M 1
FY2027 KWD 0.780
KWD 0.764 – KWD 0.796
290 M 2

Insider Trading Activity

9 transactions
Date Insider Type Shares Price Value
Mar 9, 2026
Omer Matthew
CFO
other 4,021
Nov 11, 2025
Omer Matthew
CFO
other 142,082
May 19, 2025
Omer Matthew
CFO
grant 213,970
May 14, 2025
Gajial Omer
EVP Chief Merch & Digital Off.
sell 47,303 KWD 21.460 KWD 1,015,122
May 9, 2025
Omer Matthew
CFO
other 284,425
May 9, 2025
Gajial Omer
EVP Chief Merch & Digital Off.
grant 1,425
Apr 23, 2025
Gajial Omer
EVP Chief Merch & Digital Off.
other 99,498
Apr 22, 2025
Gajial Omer
EVP Chief Merch & Digital Off.
other 13,973 KWD 20.550 KWD 287,145
Apr 17, 2025
Gajial Omer
EVP Chief Merch & Digital Off.
grant 138,186

النقاط الرئيسية

Negative free cash flow of -148.97M

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
N/A
ROIC-520.03%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
N/A
Current Ratio1.69
Interest Coverage-6.86

التقييم

P/E Ratio
-4.82
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -156.82M
ROE N/A ROA -56.60%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -148.97M
ROIC -520.03% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1.69
Interest Coverage -6.86 Dividend Yield 0.00%
Valuation
P/E Ratio -4.82 P/B Ratio N/A
P/S Ratio N/A PEG Ratio -0.08
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 755.80M Enterprise Value 959.42M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 0.0 0.0 0.0 0.0 0.0
Net Income -156.82M -117.81M 47.42M -111.41M -138.06M
EPS (Diluted) -2.70 -1.88 0.46 3.12 -2.41
Gross Profit 0.0 0.0 0.0 -1.39M -1.62M
Operating Income -169.26M -164.53M -163.39M -173.62M -156.92M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 277.08M 378.27M 590.97M 419.27M 181.04M
Total Liabilities 459.69M 403.25M 505.29M 395.49M 301.79M
Shareholders' Equity -182.61M -24.98M 85.68M 23.78M -120.75M
Total Debt 207.02M 361.58M 342.02M 347.84M 268.84M
Cash & Equivalents 3.40M 7.11M 11.01M 100.81M 10.50M
Current Assets 134.12M 217.90M 443.24M 247.96M 151.29M
Current Liabilities 79.53M 53.32M 136.38M 51.79M 36.74M